Ceftolozane/tazobactam: a novel antipseudomonal cephalosporin and β-lactamase-inhibitor combination

The management of infections caused by multidrug-resistant Gram-negative bacteria, particularly Pseudomonas aeruginosa, continues to be a significant challenge to clinicians. Ceftolozane/tazobactam is a novel antibacterial and β-lactamase-inhibitor combination that has shown appreciable activity aga...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Mai-Chi, Hsu, Donald I, Bounthavong, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848746/
https://www.ncbi.nlm.nih.gov/pubmed/24348053
http://dx.doi.org/10.2147/IDR.S36140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848746/
https://www.ncbi.nlm.nih.gov/pubmed/24348053
http://dx.doi.org/10.2147/IDR.S36140

Ejemplares similares